MYO (myomo.com) Market Value to Book Value Ratio

Myomo, Inc (MYO) - corporate logo

The competitive advantage of Myomo, Inc. (MYO) is based on exclusive patents in upper-limb robotics and support from insurance providers. Myomo, Inc. (MYO) maintains leadership in creating wearable rehabilitation systems that restore patient motor skills. The market trend for the asset shown on this price chart is accompanied by the development of a global distribution network for exoskeletons, while operating margins stand at 7.78 due to diversified component sourcing.

MYO - Myomo Inc Market-to-Book Ratio over the range 07/04/2022 - 10/28/2026

MYO (Myomo Inc.): analytical breakdowns and indicator data

- price and consensus price forecast:
Price Chart Myomo, Inc.|MYO - Analyst Median Target
- market capitalization data:
Market Value Myomo, Inc|MYO - Full Business Value
- book capitalization data:
Book Value per Share Myomo|MYO - Total Stockholders' Equity|Market Capitalization to Book Value Ratio myomo.com|MYO - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital Myomo, Inc.|MYO - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Myomo, Inc|MYO - Company Aggregate Debts|Debt to Book Capitalization Ratio Myomo, Inc|MYO - Company Long-Term Debt|Company Short-Term Debts Myomo
Fundamental valuation:Myomo, Inc.
Manufactured products of Myomo Inc.

This indicator measures the gap between the market price of shares and the company's net asset value. The ratio reflects the degree to which the business is overvalued relative to its book base. Analyzing the price-to-book ratio allows for an assessment of investor market optimism. For Myomo, Inc. (MYO), a high premium is justified by the ownership of exclusive prosthetic patents. Strict FDA control and technological barriers make intangible assets a key value driver.

Competitor analysis

Boston Scientific - Market Value to Book Value Ratio|EW (edwards.com) - Market Capitalization to Book Value|Market Value to Book Value Ratio ResMed RMD|Market Capitalization to Net Assets Insulet Corp|Zimmer Biomet Holdings, Inc. - Market Capitalization to Book Value Ratio|Market-to-Book Ratio CooperSurgical (COO)|Align Technology, Inc. - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio globusmedical.com GMED|Market Capitalization to Book Value Ratio TMDX (TransMedics Group)|ATEC - Market Capitalization to Book Value|AORT: Market Capitalization to Book Value Ratio|ENOV (Enovis Inc.) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Integra LifeSciences|Market Value to Book Value Ratio establishmentlabs.com|BBNX (Beta Bionics) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value IRADIMED Corp IRMD|Embecta Inc. (EMBC) - Market Cap to Net Assets Ratio|Market Capitalization to Net Assets Tandem Corp TNDM|AXGN (AxoGen, Inc.) - Market Capitalization to Book Value Ratio|SIBN - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Orthofix|Capitalization to Book Value Ratio Bioventus Inc|KIDS - Market Cap to Net Assets Ratio|Market Value to Book Value TMCI|Market Value to Book Value Ratio SRTA (Strata Critical Medical Inc)|Market Cap to Net Assets Ratio carlsmed.com (CARL)|RXST: Market Capitalization to Book Value Ratio|Market-to-Book Ratio ClearPoint Neuro Inc. CLPT|Stereotaxis Corp (STXS) - Market Capitalization to Book Value Ratio|STIM - Capitalization to Book Value Ratio|Sight Sciences, Inc. - Market Capitalization to Book Value Ratio|orchestrabiomed.com (OBIO) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio ANIK|Market Cap to Net Assets Ratio InspireMD Inc|Market Capitalization to Book Value Ratio ZJYL|Market Capitalization to Book Value Ratio VANI (vivani.com)|Market Value to Book Value Ratio Xtant Medical XTNT|NMTC - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Modular Med (MODD)|COCH - Market Value to Book Value|Market Capitalization to Book Value Ratio VVOS|NVNO (enVVeno Corp) - Market-to-Book Ratio|Sintx Technologies Inc - Market Value to Book Value Ratio|Market Value to Equity Ratio tenonmed.com (TNON)|Market Cap to Net Assets Ratio LFWD|Market Capitalization to Book Value Ratio autonomix.com (AMIX)|Market Capitalization to Book Value Ratio IVF|Bone Biologics Inc - Market Capitalization to Book Value|Market Value to Book Value Ratio Axonics, Inc.|BIOL: Market Capitalization to Net Assets|DYNT (dynatronics.com) - Market Value to Book Value Ratio|Paragon 28 (FNA) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio INVO (INVO Bioscience Inc.)